The delivery of healthcare at home has expanded to intravenous infusions of monoclonal antibodies. A recently developed model of care for home infusions of natalizumab for people with relapsing-remitting multiple sclerosis was evaluated. This pilot study of home infusions of natalizumab and usual care (attendance in a hospital out-patients’ clinic) compared safety, feasibility, patient satisfaction, effectiveness and costs.

中文翻译：

---

多发性硬化症患者家庭输注那他珠单抗：一项试点随机交叉试验


家庭医疗保健服务已扩展到单克隆抗体的静脉输注。对最近开发的一种针对复发缓解型多发性硬化症患者家庭输注那他珠单抗的护理模式进行了评估。这项针对那他珠单抗家庭输注和常规护理（到医院门诊就诊）的试点研究比较了安全性、可行性、患者满意度、有效性和成本。